GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Amoeba SA (XPAR:ALMIB) » Definitions » Other Income (Expense)

Amoeba (XPAR:ALMIB) Other Income (Expense) : €-7.51 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Amoeba Other Income (Expense)?

Amoeba's other income expense for the Amoeba's pretax income for the six months ended in Dec. 2023 was €-7.40 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-7.51 Mil.


Amoeba Other Income (Expense) Historical Data

The historical data trend for Amoeba's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amoeba Other Income (Expense) Chart

Amoeba Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 -0.05 0.22 -0.29 -7.51

Amoeba Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 -0.34 0.05 -0.11 -7.40

Amoeba Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-7.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amoeba  (XPAR:ALMIB) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Amoeba (XPAR:ALMIB) Business Description

Traded in Other Exchanges
Address
38 Avenue des Freres Montgolfier, Chassieu, Lyon, FRA, 69680
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.

Amoeba (XPAR:ALMIB) Headlines

No Headlines